MedTrace Logo

Epigenetics of Muscle Insulin Resistance

NCT03259984 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2019-10-14

No results posted yet for this study

Summary

The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA methylation is a normal chemical process in the body that modifies DNA. By studying this, the investigators hope to better understand the causes of insulin resistance.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Dawn K Coletta, Ph.D. · University of Arizona

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-11-02
Completion
2018-11-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03259984 on ClinicalTrials.gov